CoreFirst Bank & Trust purchased a new position in Corteva, Inc. (NYSE:CTVA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 874 shares of the company’s stock, valued at approximately $50,000.
Other large investors also recently modified their holdings of the company. Flagship Wealth Advisors LLC purchased a new position in Corteva during the fourth quarter worth about $25,000. Noble Wealth Management PBC bought a new stake in shares of Corteva during the 4th quarter valued at about $26,000. Hager Investment Management Services LLC purchased a new position in shares of Corteva during the fourth quarter worth about $27,000. Golden State Wealth Management LLC bought a new position in shares of Corteva in the fourth quarter worth approximately $32,000. Finally, Centricity Wealth Management LLC purchased a new stake in Corteva in the fourth quarter valued at approximately $34,000. 81.54% of the stock is currently owned by institutional investors.
Corteva Trading Down 0.3 %
CTVA opened at $61.91 on Wednesday. Corteva, Inc. has a one year low of $50.01 and a one year high of $66.24. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93. The business has a 50 day simple moving average of $62.50 and a two-hundred day simple moving average of $59.99. The firm has a market capitalization of $42.44 billion, a price-to-earnings ratio of 47.99, a PEG ratio of 1.68 and a beta of 0.79.
Corteva Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s payout ratio is 52.71%.
Analyst Ratings Changes
CTVA has been the subject of a number of research reports. Wells Fargo & Company boosted their price target on shares of Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. Citigroup increased their target price on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. KeyCorp lifted their price target on Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. The Goldman Sachs Group initiated coverage on Corteva in a research report on Thursday, March 13th. They set a “buy” rating and a $71.00 price objective on the stock. Finally, Oppenheimer boosted their target price on Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $68.00.
Get Our Latest Research Report on Corteva
Insider Buying and Selling
In related news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares of the company’s stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is owned by insiders.
Corteva Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Articles
- Five stocks we like better than Corteva
- What Investors Need to Know to Beat the Market
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Where Do I Find 52-Week Highs and Lows?
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Which Wall Street Analysts are the Most Accurate?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.